Monitor for 10b5-1 plan disclosures in upcoming filings; consider this a caution signal ahead of earnings or clinical updates. Absence of offsetting buy signals increases downside risk.
Price Chart
Executive Summary
Multiple insiders at Arcutis Biotherapeutics sold shares in a coordinated open-market cluster totaling $1.65M over two days, including CFO Latha Vairavan. These sales coincide with routine stock award grants, suggesting pre-arranged 10b5-1 plans. The total value represents 0.06% of market cap — modest but notable due to C-suite participation.
Key Financial Metrics
Key Facts
- Seven open-market sales totaling $1.65M occurred on March 2, 2026, by five insiders including CFO Latha Vairavan.
- Concurrent with sales, five insiders received non-cash stock grants totaling 226,000 shares ($0 value).
- Sales represent ~0.06% of $2.9B market cap — not large in absolute terms but concentrated among executives.
- All transactions occurred within a 7-day window, indicating coordinated timing, likely under 10b5-1 plans.
Financial Impact
$1.65 million in insider selling, offset by $0 in non-cash grants
Risk Factors
- Perception of insider pessimism despite likely pre-arranged trades
- Potential for follow-on selling if 10b5-1 plans are ongoing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (11 trades, 7d window) | cluster-ARQT-1772659026262 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 24, 2026 5w ago | Insider Cluster | $24.86 $26.38 | ▲ +6.11% | ▲ +5.87% | $25.16 (+1.21%) |
Aug 21, 2026 6w ago | Insider Cluster | $25.08 $25.96 | ▲ +3.51% | ▲ +4.04% | $25.16 (+0.32%) |
Aug 19, 2026 6w ago | Insider Cluster | $25.35 $25.38 | ▲ +0.12% | ▲ +0.12% | $25.16 (−0.75%) |
Aug 11, 2026 7w ago | 144 | $26.28 $23.38 | ▼ −11.04% | ▼ −9.14% | $25.16 (−4.26%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 5, 2026 8w ago | Press Release | $26.43 $23.66 | ▼ −10.48% | ▼ −11.08% | $25.16 (−4.81%) |
Aug 3, 2026 8w ago | 144 | $26.03 $23.75 | ▼ −8.76% | ▼ −7.52% | $25.16 (−3.34%) |
Jun 29, 2026 13w ago | Press Release | $26.22 $27.84 | ▲ +6.18% | ▲ +7.21% | $25.16 (−4.04%) |
Jun 18, 2026 15w ago | Insider Cluster | $26.21 $27.74 | ▲ +5.84% | ▲ +5.30% | $25.16 (−4.01%) |
Jun 9, 2026 16w ago | 8-K | $23.23 $28.78 | ▲ +23.89% | ▲ +20.27% | $25.16 (+8.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access